Merck Tbk. vs Pradiksi Gunatama Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Pradiksi Gunatama Tbk. trades at Rp7,125 (market cap 41.46T, 5.7K 24h volume). The key difference: Pradiksi Gunatama Tbk. is far larger — about 24.4× Merck Tbk.'s market cap, and Merck Tbk. is more actively traded (37.6K versus 5.7K). Which is the better fit depends on your goals.
| MERK | PGUN | |
|---|---|---|
Market Cap | 1.7T | 41.46T |
Volume | 37.6K | 5.7K |
Lot | 376 | 57 |
Turnover | 144.47M | 40.94M |
Average Price | 3,842.23 | 7,181.58 |
Value | 144.47M | 40.94M |
Indicative Equilibrium Price | 3,840 | 7,125 |
Indicative Equilibrium Volume | 7 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Pradiksi Gunatama Tbk (Company), was established on September 11, 1995 in the Republic of Indonesia in the framework of foreign investment in accordance with the Domestic Investment Law No. 1 of 1989, Juncto Law No. 12 of 1970, based on deed No. 46 dated June 21, 1996 notary Ny. Toety Juniarto.SH in Jakarta. The Company commenced commercial operations in 2002.
Read more on PGUN →